Fundraising Fox
🦊/Companies
Sign in

Cardior Pharmaceuticals GmbH

4 known investors

Find your way into Cardior Pharmaceuticals GmbH

Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.

Investors · 4

BioMedPartnersBasel · $648K – $6.5M
Hadean VenturesOslo
Inkefreported · 2 sourcesAmsterdam
Sunstone CapitalreportedFrederiksberg

In the news

Cardior Pharmaceuticals GmbH announced that it has received €64 million in funding from a group of investors -August 24, 2021 | MarketScreenermarketscreener.com · Aug 2021Cardior bags €64m in Series B Financing - European Biotechnology Magazineeuropean-biotechnology.com · Aug 2021Cardior Pharmaceuticals Demonstrates Reversal of Heart Failure with Lead Compound CDR132L | FirstWord Pharmafirstwordpharma.com · Jan 2020

Frequently asked questions

What does Cardior Pharmaceuticals GmbH do?
Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.
Who are Cardior Pharmaceuticals GmbH's investors?
Cardior Pharmaceuticals GmbH's investors include BioMedPartners, Hadean Ventures, Inkef, Sunstone Capital.